reference/29167778

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29167778

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2296-858X
pageRange	849222-
publicationName	Frontiers in Medicine
startingPage	849222
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_28be8d8bae697e728f9ae67622047377 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_236f86b34c876682269dc0a30e20d456 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_260f1bd33d3946ccf69cc1cb74a65461 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bd431624ef8d2b26337860b8b4fc6951 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e3c18600b59b2612497bf6b95256a2d6
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d59265d20b4f0d2dd52fd46f90be4651 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fc46cd0fa5f67462b19cc6adf533c8f2
bibliographicCitation	Li S, Jun T, Tyler J, Schadt E, Kao YH, Wang Z, Konig MF, Bettegowda C, Vogelstein JT, Papadopoulos N, Parsons RE, Chen R, Schadt EE, Li L, Oh WK. Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients. Front Med (Lausanne). 2022;9():849222. PMID: 35295598; PMCID: PMC8919772.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3da9814ecaa1789d84b4855bbb6d5d9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7362573a1fceeb529654890e8d982292 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_584acd5c2f223d4c34b6204d4d6f4bfe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d536abaeba0b772e2ae77f2dfb52249 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_df4871dead303e01c428c8c36094a9b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f0522cd484502b932c9e042cd4e8379 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a0e69de56b3747e05e798ddd5bad262 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6d64c85d2e0565f3b3e8604a19be757d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c6bfeeb1ea48605b4498d24e220bad2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_755c215e32d80c9410129eca77db52ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9581-8029 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b3a21a0ea75145ea662974e0cec579c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe5011264bbd616f33ccc3b0ccff2a5d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_59299312a9cb5addfb36a42aa0000abc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50d26110546744d1cb085b1bb80d3019 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1bd7131827180ca81f6e7d90fecb7bdb
date	2022-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC8919772 https://pubmed.ncbi.nlm.nih.gov/35295598 https://doi.org/10.3389/fmed.2022.849222
isPartOf	https://portal.issn.org/resource/ISSN/2296-858X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43407
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Inpatient Administration of Alpha-1-Adrenergic Receptor Blocking Agents Reduces Mortality in Male COVID-19 Patients
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6762 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fc1b42f44aeb9011478ed85af58220a1

Total number of triples: 41.